Pre-emptive Medicine in Cardiometabolic Renal Disease

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/15/c2/04/15c204be-a5ab-1cf2-1b47-149bada587f4/mza_2818802176703340354.jpg/600x600bb.jpg

Axiom Catalyst

Axiom Healthcare Strategies

39 episodes

4 days ago

Axiom Catalyst is your go-to for Life Sciences updates, news, and discussion. We will also feature guest speakers to comment on newsworthy developments. Powered by Axiom Healthcare Strategies, and hosted by Hafiz Sikder and the Think Tank Table.

Life Sciences

Science

RSS

All content for Axiom Catalyst is the property of Axiom Healthcare Strategies and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/24113157/24113157-1752157745153-61b3c212b800e.jpg

Pre-emptive Medicine in Cardiometabolic Renal Disease

Axiom Catalyst

33 minutes 58 seconds

3 months ago

Pre-emptive Medicine in Cardiometabolic Renal Disease

In this episode of the Axiom Catalyst Life Sciences Podcast, Jai Bains speaks with Dr. Gayathri Swaminath, VP of Cardiovascular at Pioneering Medicines, about the evolving role of pre-emptive medicine in cardiometabolic renal disease, with a focus on chronic kidney disease. From redefining early intervention to exploring the role of biomarkers, and multi-omics, this conversation dives into the science, system barriers, and future outlook for tackling CKD earlier and more effectively.

Listen in to learn more!